
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B371D926459733C371D0017B284DA.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="oncotarget">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5356755/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Oncotarget">
<meta name="citation_title" content="Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer">
<meta name="citation_author" content="Angel Chao">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_author" content="Ting-Chang Chang">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_author" content="Nina Lapke">
<meta name="citation_author_institution" content="ACTGenomics, Co. Ltd., Taiwan">
<meta name="citation_author" content="Shih-Ming Jung">
<meta name="citation_author_institution" content="Department of Pathology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author" content="Peter Chi">
<meta name="citation_author_institution" content="Institute of Biochemical Sciences, College of Life Science, National Taiwan University, Taiwan">
<meta name="citation_author" content="Chien-Hung Chen">
<meta name="citation_author_institution" content="ACTGenomics, Co. Ltd., Taiwan">
<meta name="citation_author" content="Lan-Yan Yang">
<meta name="citation_author_institution" content="Clinical Trial Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_author" content="Cheng-Tao Lin">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_author" content="Huei-Jean Huang">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_author" content="Hung-Hsueh Chou">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_author" content="Jui-Der Liou">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_author" content="Shu-Jen Chen">
<meta name="citation_author_institution" content="ACTGenomics, Co. Ltd., Taiwan">
<meta name="citation_author" content="Tzu-Hao Wang">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan">
<meta name="citation_author" content="Chyong-Huey Lai">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan">
<meta name="citation_author_institution" content="Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan">
<meta name="citation_publication_date" content="2016 Nov 19">
<meta name="citation_volume" content="7">
<meta name="citation_issue" content="51">
<meta name="citation_firstpage" content="85529">
<meta name="citation_doi" content="10.18632/oncotarget.13456">
<meta name="citation_pmid" content="27907908">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5356755/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5356755/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5356755/pdf/oncotarget-07-85529.pdf">
<meta name="description" content="Germline and somatic BRCA1/2 mutations define a subset of patients with ovarian cancer who may benefit from treatment with poly (ADP-ribose) polymerase inhibitors. Unfortunately, data on the frequency of BRCA1/2 germline mutations in Taiwanese ...">
<meta name="og:title" content="Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Germline and somatic BRCA1/2 mutations define a subset of patients with ovarian cancer who may benefit from treatment with poly (ADP-ribose) polymerase inhibitors. Unfortunately, data on the frequency of BRCA1/2 germline mutations in Taiwanese ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5356755/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="5356755">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.18632/oncotarget.13456"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/oncotarget-07-85529.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC5356755%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/5356755/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/5356755/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC5356755/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-oncotarget.gif" alt="Oncotarget logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Oncotarget" title="Link to Oncotarget" shape="default" href="https://www.oncotarget.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Oncotarget</button></div>. 2016 Nov 19;7(51):85529–85541. doi: <a href="https://doi.org/10.18632/oncotarget.13456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.18632/oncotarget.13456</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Oncotarget%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oncotarget%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Oncotarget%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Oncotarget%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Prevalence and clinical significance of <em>BRCA1/2</em> germline and somatic mutations in Taiwanese patients with ovarian cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chao%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Angel Chao</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Angel Chao</span></h3>
<div class="p">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chao%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Angel Chao</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chang%20TC%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Ting-Chang Chang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Ting-Chang Chang</span></h3>
<div class="p">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chang%20TC%22%5BAuthor%5D" class="usa-link"><span class="name western">Ting-Chang Chang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lapke%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Nina Lapke</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Nina Lapke</span></h3>
<div class="p">
<sup>3</sup> ACTGenomics, Co. Ltd., Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lapke%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nina Lapke</span></a>
</div>
</div>
<sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jung%20SM%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Shih-Ming Jung</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Shih-Ming Jung</span></h3>
<div class="p">
<sup>4</sup> Department of Pathology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jung%20SM%22%5BAuthor%5D" class="usa-link"><span class="name western">Shih-Ming Jung</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chi%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Peter Chi</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Peter Chi</span></h3>
<div class="p">
<sup>5</sup> Institute of Biochemical Sciences, College of Life Science, National Taiwan University, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chi%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter Chi</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20CH%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Chien-Hung Chen</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Chien-Hung Chen</span></h3>
<div class="p">
<sup>3</sup> ACTGenomics, Co. Ltd., Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20CH%22%5BAuthor%5D" class="usa-link"><span class="name western">Chien-Hung Chen</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20LY%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Lan-Yan Yang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Lan-Yan Yang</span></h3>
<div class="p">
<sup>6</sup> Clinical Trial Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20LY%22%5BAuthor%5D" class="usa-link"><span class="name western">Lan-Yan Yang</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20CT%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Cheng-Tao Lin</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Cheng-Tao Lin</span></h3>
<div class="p">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lin%20CT%22%5BAuthor%5D" class="usa-link"><span class="name western">Cheng-Tao Lin</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20HJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Huei-Jean Huang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Huei-Jean Huang</span></h3>
<div class="p">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20HJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Huei-Jean Huang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chou%20HH%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Hung-Hsueh Chou</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Hung-Hsueh Chou</span></h3>
<div class="p">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chou%20HH%22%5BAuthor%5D" class="usa-link"><span class="name western">Hung-Hsueh Chou</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liou%20JD%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Jui-Der Liou</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Jui-Der Liou</span></h3>
<div class="p">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liou%20JD%22%5BAuthor%5D" class="usa-link"><span class="name western">Jui-Der Liou</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20SJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Shu-Jen Chen</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Shu-Jen Chen</span></h3>
<div class="p">
<sup>3</sup> ACTGenomics, Co. Ltd., Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20SJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Shu-Jen Chen</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20TH%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Tzu-Hao Wang</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Tzu-Hao Wang</span></h3>
<div class="p">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">
<sup>7</sup> School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20TH%22%5BAuthor%5D" class="usa-link"><span class="name western">Tzu-Hao Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lai%20CH%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Chyong-Huey Lai</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Chyong-Huey Lai</span></h3>
<div class="p">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div class="p">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lai%20CH%22%5BAuthor%5D" class="usa-link"><span class="name western">Chyong-Huey Lai</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="A1">
<sup>1</sup> Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div id="A2">
<sup>2</sup> Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div id="A3">
<sup>3</sup> ACTGenomics, Co. Ltd., Taiwan</div>
<div id="A4">
<sup>4</sup> Department of Pathology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan</div>
<div id="A5">
<sup>5</sup> Institute of Biochemical Sciences, College of Life Science, National Taiwan University, Taiwan</div>
<div id="A6">
<sup>6</sup> Clinical Trial Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan</div>
<div id="A7">
<sup>7</sup> School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline"><strong>Correspondence to:</strong><em>Shu-Jen Chen</em>, <span>sjchen@actgenomics.com</span></p>
</div>
<div class="fn" id="cor2">
<sup>✉</sup><p class="display-inline"><em>Tzu-Hao Wang</em>, <span>knoxtn@cgmh.org.tw</span></p>
</div>
<div class="fn" id="cor3">
<sup>✉</sup><p class="display-inline"><em>Chyong-Huey Lai</em>, <span>laich46@cgmh.org.tw</span></p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2016 Aug 20; Accepted 2016 Oct 28; Collection date 2016 Dec 20.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright: © 2016 Chao et al.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC5356755  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27907908/" class="usa-link">27907908</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Germline and somatic <em>BRCA1/2</em> mutations define a subset of patients with ovarian cancer who may benefit from treatment with poly (ADP-ribose) polymerase inhibitors. Unfortunately, data on the frequency of <em>BRCA1/2</em> germline mutations in Taiwanese patients with ovarian cancer are scarce, with the prevalence of somatic mutations being unknown. We aim to investigate the occurrence of <em>BRCA1/2</em> mutations in 99 Taiwanese patients with ovarian cancer which included serous (n = 46), endometrioid (n = 24), and clear cell (n = 29) carcinomas. <em>BRCA1/2</em> mutations were identified using next-generation sequencing of formalin-fixed paraffin-embedded tumor samples. Pathogenic variants (<em>BRCA1</em>: n = 7; <em>BRCA2</em>: n = 6) were detected in 12.1% (12/99) of the study patients. Somatic and germline <em>BRCA1/2</em> mutation rates in serous ovarian cancer are 4/46 (8.7%) and 8/46 (17%), respectively. All of the pathogenic <em>BRCA1/2</em> mutations were identified in serous carcinoma samples (12/46; 26.1%). One-third (4/12) of the deleterious <em>BRCA1/2</em> mutations occurred in tumor tissues only (somatic mutations). All of them coexisted with loss of heterozygosity, resulting in biallelic <em>BRCA</em> inactivation. Five novel pathogenic mutations were identified, including four somatic variants (<em>BRCA1</em> p.S242fs, <em>BRCA1</em> p.F989fs, <em>BRCA1</em> p.G1738fs, and <em>BRCA2</em> p.D1451fs) and a germline variant (<em>BRCA2</em> p.E260fs). We also detected additional six novel mutations (three in BRCA1 and three in BRCA2) with pathogenic potentials. We conclude that <em>BRCA1/2</em> mutations are common in Taiwanese patients with serous ovarian carcinoma and similar to mutation rates in other ethnic groups. The analysis of <em>BRCA1/2</em> somatic mutations is crucial for guiding therapeutic decisions in ovarian cancer.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> BRCA1/2, germline mutations, somatic mutations, ovarian cancer</p></section></section><section id="s1"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>Ovarian cancer is the eighth most common cause of cancer death in Taiwanese women [<a href="#R1" class="usa-link" aria-describedby="R1">1</a>]. Approximately 238,700 new cases are diagnosed each year worldwide, which are responsible for 151,900 deaths [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>]. The 5-year survival rates of ovarian cancer are stage-dependent and range between 27% and 92% [<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]. Common adverse prognostic factors include advanced stages and disease recurrence [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>].</p>
<p>Mutations of the <em>BRCA1/2</em> genes occur in approximately 20% of high-grade ovarian serous carcinoma [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>] and are associated with better survival outcomes [<a href="#R6" class="usa-link" aria-describedby="R6">6</a>–<a href="#R10" class="usa-link" aria-describedby="R10">10</a>]. Inactivating <em>BRCA1/2</em> mutations portend an increased risk of malignant transformation because of their ability to impair homologous recombination-dependent DNA repair [<a href="#R11" class="usa-link" aria-describedby="R11">11</a>]. Conversely, inactivation of homologous recombination renders <em>BRCA1/2</em> mutant tumors sensitive to platinum [<a href="#R6" class="usa-link" aria-describedby="R6">6</a>, <a href="#R8" class="usa-link" aria-describedby="R8">8</a>, <a href="#R10" class="usa-link" aria-describedby="R10">10</a>, <a href="#R12" class="usa-link" aria-describedby="R12">12</a>] and poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) [<a href="#R13" class="usa-link" aria-describedby="R13">13</a>]. Unfortunately, the identification of patients who could benefit from PARPi remains challenging.</p>
<p>The United States (US) Food and Drug Administration (FDA) approved the use of the PARPi olaparib when <em>BRCA1/2</em> germline mutations are present [<a href="#R14" class="usa-link" aria-describedby="R14">14</a>, <a href="#R15" class="usa-link" aria-describedby="R15">15</a>]. However, the US FDA did not approve olaparib for patients who carry somatic <em>BRCA1/2</em> mutations only (approximately one third of all <em>BRCA1/2</em> mutant patients) [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R6" class="usa-link" aria-describedby="R6">6</a>]. In contrast, the European Medicines Agency (EMA) approved olaparib for ovarian cancer patients who have either germline or somatic <em>BRCA1/2</em> mutations [<a href="#R13" class="usa-link" aria-describedby="R13">13</a>, <a href="#R16" class="usa-link" aria-describedby="R16">16</a>]. Besides such regulatory discrepancies, not all patients with pathogenic <em>BRCA</em> mutations successfully respond to PARPi. A potential explanation lies in the fact that <em>BRCA</em> mutations require a loss of heterozygosity (LOH) to cause biallelic <em>BRCA</em> inactivation [<a href="#R17" class="usa-link" aria-describedby="R17">17</a>]. Although the loss of a single <em>BRCA</em> allele is sufficient <em>per se</em> to induce genomic instability and drive malignant transformation [<a href="#R18" class="usa-link" aria-describedby="R18">18</a>, <a href="#R19" class="usa-link" aria-describedby="R19">19</a>], cells with monoallelic <em>BRCA</em> inactivation might not be sensitive to PARPi [<a href="#R20" class="usa-link" aria-describedby="R20">20</a>]. Unfortunately, the occurrence of biallelic inactivation of <em>BRCA1/2</em> has not been specifically analyzed in most of the available studies. In addition, few data on somatic and germline <em>BRCA1/2</em> mutations have been published in patients with Asian descent, and for Taiwanese patients, even the prevalence of germline mutations is only insufficiently investigated [<a href="#R21" class="usa-link" aria-describedby="R21">21</a>]. Notably, clear cell carcinomas are underrepresented in most studies because of their low incidence in North America and Europe (1−12% of all cases) compared to Asia (13−25%) [<a href="#R22" class="usa-link" aria-describedby="R22">22</a>–<a href="#R24" class="usa-link" aria-describedby="R24">24</a>]. <em>BRCA1/2</em> mutations have been reported in clear cell carcinomas [<a href="#R8" class="usa-link" aria-describedby="R8">8</a>, <a href="#R25" class="usa-link" aria-describedby="R25">25</a>, <a href="#R26" class="usa-link" aria-describedby="R26">26</a>] and endometrioid tumors [<a href="#R6" class="usa-link" aria-describedby="R6">6</a>, <a href="#R8" class="usa-link" aria-describedby="R8">8</a>, <a href="#R27" class="usa-link" aria-describedby="R27">27</a>–<a href="#R29" class="usa-link" aria-describedby="R29">29</a>], but their clinical significance requires further scrutiny.</p>
<p>Although Sanger sequencing is traditionally used for identifying <em>BRCA</em> mutations in clinical samples [<a href="#R30" class="usa-link" aria-describedby="R30">30</a>], next generation sequencing (NGS) has recently allowed obtaining a complete coverage of all exonic regions. This is essential since <em>BRCA</em> mutations differ among patients of different ethnicity [<a href="#R31" class="usa-link" aria-describedby="R31">31</a>]. Somatic <em>BRCA1/2</em> mutations can be successfully identified by NGS in formalin-fixed paraffin-embedded (FFPE) samples, but biallelic inactivation has not been thus far investigated [<a href="#R29" class="usa-link" aria-describedby="R29">29</a>].</p>
<p>Using NGS (covering all of the <em>BRCA1/2</em> exons as well as the exon-intron junctions) of FFPE specimens obtained from 99 Taiwanese patients with ovarian cancer, we analyzed 1) germline and somatic <em>BRCA1/2</em> mutations and 2) the occurrence of biallelic <em>BRCA1/2</em> inactivation.</p></section><section id="s2"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="s2_1"><h3 class="pmc_sec_title">Analytic workflow</h3>
<p>We included 99 patients with ovarian cancer who were unselected for their family history of malignancies. The histological subtypes included serous (n = 46), endometrioid (n = 24), and clear cell (n = 29) carcinomas. <a href="#SD1" class="usa-link">Supplementary Figure S1</a> shows the workflow for the identification of BRCA1/2 variants identified in the current study.</p></section><section id="s2_2"><h3 class="pmc_sec_title">Detection of <em>BRCA1</em> and <em>BRCA2</em> variants by NGS and Sanger sequencing</h3>
<p>NGS was used for <em>BRCA1/2</em> sequencing of FFPE tumor samples (average sequencing depth: &gt;5700×; mean uniformity: 91.1%). Forty-four nonsynonymous and splice variants were identified in 36 patients. Of them, 13 were pathogenic variants (Table <a href="#T1" class="usa-link">1</a>), 23 VUS (<a href="#SD1" class="usa-link">Supplementary Table S1</a>), and eight benign variants. NGS-identified variants with an allele frequency &gt;10% were confirmed by Sanger sequencing of tumor samples. To distinguish between germline and somatic mutations, Sanger sequencing was also performed for normal tissues (for all pathogenic variants; 13/13 and for all VUS with available control samples; 22/23). In addition to Sanger sequencing, NGS was performed in normal control samples when a sufficient amount of DNA was available (for pathogenic variants; 10/13 and for VUS; 18/23). A 100% concordance rate between the results of NGS and Sanger sequencing in tumor samples was observed.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1. <em>BRCA</em> variant description and clinical characteristics for patients with pathogenic BRCA1/2 mutations.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<thead><tr>
<th align="left" valign="middle" rowspan="1" colspan="1">ID</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Germline (G)/ Somatic (S)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Gene</th>
<th align="center" valign="middle" colspan="2" rowspan="1">Change for nucleotides (nt) and amino acids (aa)#</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Variant classification (ARUP/ BIC/ BRCA Share/ ClinVar/ LOVD)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Type§</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Age (y)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">FIGO stage/grade</th>
<th align="center" valign="middle" rowspan="1" colspan="1">FH¶</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">nt</td>
<td align="center" valign="middle" rowspan="1" colspan="1">aa</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr><td align="left" valign="middle" colspan="10" rowspan="1">Recurrent variants (n = 2)</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.5164_5165 delAG</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S1722fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">path/ path/ NA/ path/ path</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">50</td>
<td align="center" valign="middle" rowspan="1" colspan="1">IV/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.5164_5165 delAG</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S1722fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">path/ path/ NA/ path/ path</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">57</td>
<td align="center" valign="middle" rowspan="1" colspan="1">I/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr><td align="left" valign="middle" colspan="10" rowspan="1">Unique variants (n = 11)</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.2188G&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.E730*</td>
<td align="center" valign="middle" rowspan="1" colspan="1">path/ path/ NA/ path/ NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">53</td>
<td align="center" valign="middle" rowspan="1" colspan="1">IV/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">4</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.2387C&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.T796I</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA/ VUS/ NA/ VUS/ path</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">42</td>
<td align="center" valign="middle" rowspan="1" colspan="1">III/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">5</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.5332+1G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Œ_splice</td>
<td align="center" valign="middle" rowspan="1" colspan="1">path/ VUS/ path/ path/ path</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">48</td>
<td align="center" valign="middle" rowspan="1" colspan="1">III/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">6</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.3858_3861 delTGAG</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S1286fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">path/ path/ NA/ path/ path</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">56</td>
<td align="center" valign="middle" rowspan="1" colspan="1">III/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">6</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.8488-1G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Œ_splice</td>
<td align="center" valign="middle" rowspan="1" colspan="1">path/ NA/ NA/ VUS/ path</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">56</td>
<td align="center" valign="middle" rowspan="1" colspan="1">III /3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.2339C&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S780*</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA/ NA/ path/ NA/ NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">71</td>
<td align="center" valign="middle" rowspan="1" colspan="1">II/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">8</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.773_774 delAA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.E260fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA/ NA/ NA/ NA/ NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">69</td>
<td align="center" valign="middle" rowspan="1" colspan="1">II/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.726delT</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S242fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA/ NA/ NA/ NA/ NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">78</td>
<td align="center" valign="middle" rowspan="1" colspan="1">III/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">10</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.2964delA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.F989fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA/ NA/ NA/ NA/ NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">63</td>
<td align="center" valign="middle" rowspan="1" colspan="1">III/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">11</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.5211_5212 delAG</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.G1738fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA/ NA/ NA/ NA/ NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">49</td>
<td align="center" valign="middle" rowspan="1" colspan="1">III/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">12</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.4351delG</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.D1451fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA/ NA/ NA/ NA/ NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">65</td>
<td align="center" valign="middle" rowspan="1" colspan="1">III/ 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p9">
<p>#<em>HGVSp</em> - the Human Genome Variation Society (HGVS) protein sequence name. The Annotation is based on the BRCA1 transcript ENSG00000012048 (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294</a>) and the BRCA2 transcriptENSG00000139618 (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059</a>). §Histological subtype; ser = Serous. ¶ Family history (FH) refers to a positive history of breast and/or ovarian cancer in the first- and second-degree relatives.</p>
<p>Cases in bold letter are novel mutations.</p>
<p>Databases: BIC (Breast Cancer Information Core, <a href="http://research.nhgri.nih.gov/bic/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://research.nhgri.nih.gov/bic/</a>), ClinVar (<a href="http://www.ncbi.nlm.nih.gov/clinvar/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.ncbi.nlm.nih.gov/clinvar/</a>) database, LOVD (Leiden Open Variation Database, <a href="http://www.lovd.nl/3.0/home" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.lovd.nl/3.0/home</a>), ARUP (<a href="http://arup.utah.edu/database/BRCA/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://arup.utah.edu/database/BRCA/</a>) database and BRCA Share (<a href="http://www.umd.be/BRCA1/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.umd.be/BRCA1/</a>) database</p>
<p>Abbreviations: NA, not applicable; path, pathogenic; VUS, variant of uncertain significance; y, years.</p>
</div></div></section></section><section id="s2_3"><h3 class="pmc_sec_title">Patient characteristics and distribution of <em>BRCA1/2</em> mutations in this cohort</h3>
<p>The distribution of pathogenic and potentially pathogenic <em>BRCA1</em> and <em>BRCA2</em> variants according to tumor histological subtypes is depicted in Figure <a href="#F1" class="usa-link">1</a>. Table <a href="#T2" class="usa-link">2</a> summarizes the patient characteristics according to the <em>BRCA</em> mutation status.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1. BRCA1/2 genetic variants identified in the study cohort.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3218/5356755/103823d302b6/oncotarget-07-85529-g001.jpg" loading="lazy" height="415" width="600" alt="Figure 1"></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of pathogenic <em>BRCA1/2</em> mutations according to different histological subtypes. The recurrent <em>BRCA2</em> VUS p.S1946P was deemed to be pathogenic owing to its occurrence in two sisters with ovarian cancer (one with clear cell carcinoma and the other with serous carcinoma).</p></figcaption></figure><section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2. Clinical characteristics of the study patients according to the <em>BRCA</em> mutation status.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<thead>
<tr>
<th align="center" valign="middle" rowspan="1" colspan="1"></th>
<th align="center" valign="middle" rowspan="1" colspan="1"></th>
<th align="center" valign="middle" rowspan="1" colspan="1">Entire cohort</th>
<th align="center" valign="middle" rowspan="1" colspan="1">
<em>BRCA</em>-positive patients</th>
<th align="center" valign="middle" rowspan="1" colspan="1">
<em>BRCA</em>-negative patients</th>
<th align="center" valign="middle" rowspan="1" colspan="1">P</th>
</tr>
<tr>
<th align="left" valign="middle" rowspan="1" colspan="1"></th>
<th align="left" valign="middle" rowspan="1" colspan="1"></th>
<th align="left" valign="middle" rowspan="1" colspan="1">
<strong>n (%)</strong>
</th>
<th align="left" valign="middle" rowspan="1" colspan="1">
<strong>n (%)</strong>
</th>
<th align="left" valign="middle" rowspan="1" colspan="1">
<strong>n (%)</strong>
</th>
<th align="left" valign="middle" rowspan="1" colspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">99 (100)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12 (12.1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">87 (87.9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Histology</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.001</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">Serous carcinoma</td>
<td align="center" valign="middle" rowspan="1" colspan="1">46 (46.5)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12 (26.1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">34 (73.9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">Endometrioid carcinoma</td>
<td align="center" valign="middle" rowspan="1" colspan="1">24 (24.2)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">24 (100)</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">Clear cell carcinoma</td>
<td align="center" valign="middle" rowspan="1" colspan="1">29 (29.3)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">29 (100)</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Age, years</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.069</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">Median</td>
<td align="center" valign="middle" rowspan="1" colspan="1">52</td>
<td align="center" valign="middle" rowspan="1" colspan="1">56</td>
<td align="center" valign="middle" rowspan="1" colspan="1">52</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">Range</td>
<td align="center" valign="middle" rowspan="1" colspan="1">23−83</td>
<td align="center" valign="middle" rowspan="1" colspan="1">42−78</td>
<td align="center" valign="middle" rowspan="1" colspan="1">23−83</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">Mean ± SD</td>
<td align="center" valign="middle" rowspan="1" colspan="1">52.9 ± 11.1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">58.4 ± 10.8</td>
<td align="center" valign="middle" rowspan="1" colspan="1">52.2 ± 11.0</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">FIGO stage</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.228</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">I, II</td>
<td align="center" valign="middle" rowspan="1" colspan="1">42 (42.4)*</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3 (7.1)#</td>
<td align="center" valign="middle" rowspan="1" colspan="1">39 (92.9)#</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">III, IV</td>
<td align="center" valign="middle" rowspan="1" colspan="1">57 (57.6)*</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9 (15.8)§</td>
<td align="center" valign="middle" rowspan="1" colspan="1">48 (84.2)§</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Grade※</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.579</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5 (7.1)¶</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0 (0) ǂ</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5 (100) ǂ</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">2, 3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">65 (92.9)¶</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12 (18.5)ψ</td>
<td align="center" valign="middle" rowspan="1" colspan="1">53 (81.5)ψ</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p15">
<p>Patients with pathogenic <em>BRCA1/2</em> mutations were considered as <em>BRCA</em>-positive, whereas the remaining patients were regarded as <em>BRCA</em>-negative. Comparisons between <em>BRCA</em>-positive and <em>BRCA</em>-negative patients were performed with Fisher's exact tests, χ<sup>2</sup>tests, or Student's <em>t</em>-tests, as appropriate.</p>
<p>※Clear cell carcinomas were not graded.</p>
<p>*Percentage calculated on the entire cohort (n = 99).</p>
<p>#Percentage calculated on patients with FIGO stages I and II (n = 42).</p>
<p>§ Percentage calculated on patients with FIGO stages III and IV (n = 57).</p>
<p>¶Percentage calculated on patients whose tumors were graded (n = 70).</p>
<p>ǂPercentage calculated on patients with grade 1 tumors (n = 5).</p>
<p>ψPercentage calculated on patients with grade 2–3 tumors (n = 65).</p>
</div></div></section><p>Twelve patients carried pathogenic <em>BRCA1/2</em> mutations. Specifically, <em>BRCA1/2</em> germline mutations were identified in seven patients (<em>BRCA1</em>, n = 3; <em>BRCA2</em>, n = 4), <em>BRCA1/2</em> somatic mutations in four patients (<em>BRCA1</em>, n = 3; <em>BRCA2,</em> n = 1), whereas one patient carried both a <em>BRCA1</em> germline mutation and a <em>BRCA2</em> somatic mutation. All of the 12 <em>BRCA</em>-positive patients had a diagnosis of serous ovarian carcinomas (P = 0.001). The frequencies of <em>BRCA1/2</em> pathogenic mutations in the entire cohort and the subgroup of patients with serous carcinoma were 12.1% (12/99) and 26.1% (12/46), respectively. Somatic and germline <em>BRCA1/2</em> mutation rates in serous ovarian cancer are 4/46 (8.7%) and 8/46 (17%), respectively. The mean age at onset for patients with and without pathogenic <em>BRCA1/2</em> variants was 56 years and 52 years, respectively (P = 0.069). Carriers of <em>BRCA</em> germline mutations tended to have a lower median age at diagnosis (55 years) compared with women bearing only somatic mutations (64 years). In the entire study cohort, 57.6% of patients (n = 57) had advanced disease (FIGO stage III–IV). Moreover, 92.9% of patients (n = 65) with serous or endometrioid carcinomas had high-grade malignancies. Of them, 12 patients harbored pathogenic <em>BRCA1/2</em> variants. Tumor grade is not routinely determined in clear cell carcinoma [<a href="#R32" class="usa-link" aria-describedby="R32">32</a>]. Notably, we observed a recurrent <em>BRCA2</em> variant of uncertain significance (VUS) in two sisters (one with clear cell carcinoma and the other with serous carcinoma; Figure <a href="#F1" class="usa-link">1</a>).</p></section><section id="s2_4"><h3 class="pmc_sec_title">Pathogenic variants in <em>BRCA1</em> and <em>BRCA2</em>
</h3>
<p>Thirteen pathogenic <em>BRCA1/2</em> variants were identified in 12 patients (Table <a href="#T1" class="usa-link">1</a>). Two patients carried the same variant (<em>BRCA2</em> p.S1722fs), whereas one patient (subject 6) had two pathogenic variants (one in <em>BRCA1</em> and one in <em>BRCA2</em>). Of the 13 pathogenic variants, eight were frameshift mutations, two nonsense mutations, one missense mutation, and two splice donor variants. Seven mutations were detected in <em>BRCA1</em> and five in <em>BRCA2</em>. Five novel frameshift mutations were identified, including four somatic variants (<em>BRCA1</em> p.S242fs, <em>BRCA1</em> p.F989fs, <em>BRCA1</em> p.G1738fs, and <em>BRCA2</em> p.D1451fs) and a germline variant (<em>BRCA2</em> p.E260fs; Figure <a href="#F2" class="usa-link">2</a> and <a href="#SD1" class="usa-link">Supplementary Figure S2</a>). There were seven pathogenic <em>BRCA1/2</em> germline mutations and five pathogenic somatic mutations (Figure <a href="#F2" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Pathogenic BRCA1/2 variants identified in the study cohort according to their amino acid position.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3218/5356755/1bd741ab1a38/oncotarget-07-85529-g002.jpg" loading="lazy" height="445" width="600" alt="Figure 2"></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The recurrent <em>BRCA2</em> VUS p.S1946P—deemed to be pathogenic owing to its occurrence in two sisters with ovarian cancer—is included. However, splice site mutations are not displayed.</p></figcaption></figure></section><section id="s2_5"><h3 class="pmc_sec_title">VUS and benign variants in <em>BRCA1</em> and <em>BRCA2</em>
</h3>
<p>Of the 99 patients, 19.2 % (n = 19) had <em>BRCA1/2</em> VUS, all of them being missense variants (<a href="#SD1" class="usa-link">Supplementary Table S1</a>). The histological subtypes in the 19 patients with <em>BRCA1/2</em> VUS included serous (n = 10; 52.6%), endometrial (n = 5; 26.3%), and clear cell (n = 4; 21.2%) carcinomas. One patient with serous ovarian cancer (subject 7) carried an additional pathogenic variant. A total of 23 VUS were detected, with two patients harboring two VUS (subject 22 and 26) and one patient harboring three VUS (subject 14). One of the three VUS identified in this patient was also evident in another study participant (subject 13). Fifteen (63.6%) and seven (30.4%) VUS were germline and somatic, respectively. One <em>BRCA2</em> variant was not classifiable because DNA from non-tumor control tissues was not available. Four benign variants were identified in eight patients, i.e., <em>BRCA1</em> variants p.V1247I and p.M1628T, <em>BRCA2</em> variant p.I1929V (identified in four patients), and p.R2842H (identified in two patients).</p>
<p>Nine of the detected VUS have not been previously described. Of note, six novel VUS (three in BRCA1 and three in BRCA2) are predicted to be pathogenic by at least one of Grantham/ SIFT/ Polyphen and not present in 997 healthy volunteers (<a href="#SD1" class="usa-link">Supplementary Table S1</a>), suggesting their pathogenic potential.</p></section><section id="s2_6"><h3 class="pmc_sec_title">Identification of a potentially pathogenic <em>BRCA</em> VUS</h3>
<p>Three patients carrying a VUS had a family history of breast or ovarian cancer in the absence of any additional pathogenic <em>BRCA</em> variant. One patient (subject 24) carried a variant predicted to be pathogenic according to the Grantham and SIFT scores but classified as benign by PolyPhen. The remaining two patients were two sisters (one with clear cell carcinoma and the other with serous carcinoma) who carried the <em>BRCA2</em> VUS p.S1946P (predicted to be pathogenic by Grantham but classified as benign by SIFT and PolyPhen). The sister with serous carcinoma carried a <em>BRCA2</em> LOH (Table <a href="#T3" class="usa-link">3</a>), consistent with the two-hit hypothesis of tumor suppressor gene inactivation. The variant is rare in healthy subjects of the Taiwanese population (<a href="#SD1" class="usa-link">Supplementary Table S1</a>). To shed more light on the potential pathogenic role of the <em>BRCA2</em> VUS p.S1946P, the family history of cancer was analyzed (Figure <a href="#F3" class="usa-link">3</a>). Among the patients’ four siblings, no cases of cancer were evident. The analysis of germline variants in the patient siblings revealed that two of the patients’ sisters were <em>BRCA2</em> p.S1946P carriers, whereas the other sister and the brother were not. From the paternal side, the only known case of malignancy was a lung cancer in a paternal cousin. However, the patients’ mother had pancreatic cancer and their maternal uncle (as well as his son) had colorectal cancer. Although hereditary cancer was plausible, no samples were available from the three family members to investigate the presence of the <em>BRCA2</em> VUS p.S1946P. However, the tumor samples of the two ovarian cancer patients were analyzed for the presence of pathogenic variants in the coding regions of the 29 genes involved in DNA repair (<em>ATM, ATR, BLM, BRIP1, CHEK1, CHEK2, ERCC1, FANCA, FANCC, FANCD2, FANCF, MLH1, MRE11A, MSH2, MSH6, PALB2, PER1, PMS1, PMS2, PRKDC, PTEN, RAD50, RECQL4, SMUG1, TP53, WRN, XPA, XPC,</em> and <em>XRCC2)</em>. However, no shared pathogenic variants were evident (data not shown). Notably, the <em>BRCA2</em> VUS p.S1946P is located nearby the BRC motif (Figure <a href="#F2" class="usa-link">2</a>) which is essential for BRCA2-mediated recombination repair. We thus speculate that the serine-to-proline amino substitution may potentially exert pathogenic effects via an altered BRC conformation.</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">Table 3. Clinical feasibility of PARP inhibitors in patients harboring pathogenic <em>BRCA1/2</em> mutations and in two sisters carrying the <em>BRCA2</em> VUS p.S1946P.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<thead><tr>
<th align="left" valign="middle" rowspan="1" colspan="1">ID</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Variant classification</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Gene</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Amino acid change#</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Variant frequency (%)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Germline (G)/ somatic (S)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">LOH/ biallelic inactivation</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Eligibility for PARPi (USFDA label)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Eligibility for PARPi (EMA label)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S1722fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">78</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S1722fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">74</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.E730*</td>
<td align="center" valign="middle" rowspan="1" colspan="1">77</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">4ψ</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.T796I</td>
<td align="center" valign="middle" rowspan="1" colspan="1">53</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unknown§</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">5</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Œ_splice</td>
<td align="center" valign="middle" rowspan="1" colspan="1">78</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">6</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S1286fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">62</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S780*</td>
<td align="center" valign="middle" rowspan="1" colspan="1">80</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">8</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.E260fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">75</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S242fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">79</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">10</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.F989fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">59</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">11</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.G1738fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">68</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">12</td>
<td align="center" valign="middle" rowspan="1" colspan="1">pathogenic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.D1451fs</td>
<td align="center" valign="middle" rowspan="1" colspan="1">43</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">13</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S1946P</td>
<td align="center" valign="middle" rowspan="1" colspan="1">75</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes¶</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes¶</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">14</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" rowspan="1" colspan="1">BRCA2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.S1946P</td>
<td align="center" valign="middle" rowspan="1" colspan="1">48</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes¶</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes¶</td>
</tr>
<tr>
<td align="left" valign="middle" colspan="6" rowspan="1">
<strong>Patients eligible for PARPi (Yes/Unknown/No)</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1">
<strong>10/0/4</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
<strong>14/0/0</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p30">
<p>ψPatient 4 harbored an additional somatic pathogenic BRCA2 variant characterized by a low frequency (6%). #<em>HGVSp</em> - the Human Genome Variation Society (HGVS) protein sequence name. The Annotation is based on the BRCA1 transcript ENSG00000012048 (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294</a>) and the BRCA2 transcript ENSG00000139618 (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059</a>). §The SNP analysis did not allow a conclusion about the presence of an LOH. ¶Based on the assumption that the VUS p.S1946P can be classified as pathogenic.</p>
<p>Abbreviations: EMA, European Medicines Agency; LOH, loss of heterozygosity;PARPi, poly (ADP-ribose) polymerase inhibitors; USFDA, United States Food and Drug Administration; VUS, variant of uncertain significance.</p>
</div></div></section><figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3. Family tree of the two sisters with ovarian cancer harboring the BRCA2 VUS p.S1946P.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3218/5356755/74b279b976ba/oncotarget-07-85529-g003.jpg" loading="lazy" height="456" width="600" alt="Figure 3"></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The asterisks denote subjects who have been tested for the <em>BRCA2</em> VUS p.S1946P. Subjects with and without the variant of interest are reported as E+ and E-, respectively.</p></figcaption></figure></section><section id="s2_7"><h3 class="pmc_sec_title">Biallelic <em>BRCA1/2</em> inactivation and its therapeutic implications</h3>
<p>We hypothesized that the presence of a biallelic <em>BRCA</em> inactivation (regardless of the germline or somatic origin of the investigated variant) may identify patients who benefit from PARPi. The presence of LOH was tested in 14 patients, of whom 12 had pathogenic <em>BRCA</em> mutations (Table <a href="#T3" class="usa-link">3</a>) and the remaining two were the sisters harboring the <em>BRCA2</em> germline variant p.S1946P. One patient carried both a germline and a somatic <em>BRCA</em> mutation (subject 6), but only the germline mutation was tested. A biallelic inactivation of the mutated <em>BRCA</em> gene by LOH was detected in 12 patients (85.7%). Importantly, LOH was identified in all of the four patients who carried somatic pathogenic <em>BRCA</em> mutations. Of the 10 patients with germline <em>BRCA</em> mutations, eight had a LOH, whereas no LOH could be detected in two patients. However, in one case the tumor purity was very low, which is insufficient for LOH detection. According to the US FDA, the use of PARPi in our patients would be limited to cases with <em>BRCA</em> germline mutations (n = 10), whereas all patients were eligible for PARPi under the EMA label.</p></section></section><section id="s3"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>Herein we reported five novel pathogenic <em>BRCA1/2</em> mutations (Table <a href="#T1" class="usa-link">1</a>) and six novel VUS with pathogenic potential (<a href="#SD1" class="usa-link">Supplementary Table S1</a>) in patients with ovarian cancer. These results expand our knowledge on the occurrence of both germline and somatic <em>BRCA1/2</em> mutations in Taiwanese patients with different histological subtypes of ovarian cancer. Screening of <em>BRCA</em> mutations in patients with ovarian cancer may have implications for allocating patients to PARPi.</p>
<p>We also confirmed the findings of a recent report regarding the feasibility of using FFPE tumor samples for NGS analysis of alterations in the <em>BRCA1/2</em> genes [<a href="#R29" class="usa-link" aria-describedby="R29">29</a>]. To our knowledge, only one <em>BRCA1</em> germline stop mutation has been previously identified by single-strand conformation polymorphism in a sample of 68 Taiwanese patients with ovarian cancer [<a href="#R21" class="usa-link" aria-describedby="R21">21</a>]. By using NGS, we were able to identify deleterious <em>BRCA1/2</em> mutations in 12.1% of our patients, with germline mutations being evident in 8.1% of the samples. A similar prevalence of germline mutations has been reported in Chinese patients (6.9%) [<a href="#R33" class="usa-link" aria-describedby="R33">33</a>], whereas a higher frequency has been observed in Japanese (12.6%) [<a href="#R28" class="usa-link" aria-describedby="R28">28</a>] and Western cohorts (13.2−15.3%) [<a href="#R8" class="usa-link" aria-describedby="R8">8</a>, <a href="#R34" class="usa-link" aria-describedby="R34">34</a>, <a href="#R35" class="usa-link" aria-describedby="R35">35</a>]. A Korean study found <em>BRCA1/2</em> mutations in 13.5% of patients who had a negative family history [<a href="#R36" class="usa-link" aria-describedby="R36">36</a>]. The prevalence of pathogenic germline mutations identified in our patients with serous tumors (17.4%) was in accordance with that of Japanese (16.2%) [<a href="#R28" class="usa-link" aria-describedby="R28">28</a>].</p>
<p>The combined prevalence of <em>BRCA1/2</em> germline and somatic mutations in patients with ovarian cancer differs according to the detection method used (Table <a href="#T4" class="usa-link">4</a>). However, the reported frequency of <em>BRCA1/2</em> mutations in patients with high-grade serous carcinoma has been shown to vary between 19 and 30% [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R6" class="usa-link" aria-describedby="R6">6</a>, <a href="#R27" class="usa-link" aria-describedby="R27">27</a>, <a href="#R29" class="usa-link" aria-describedby="R29">29</a>], which is in line with the results of our study (26.1%). Similarly, the observed frequency of somatic mutations in our cohort (33%) is in line with the published literature (16−40%) [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R6" class="usa-link" aria-describedby="R6">6</a>, <a href="#R27" class="usa-link" aria-describedby="R27">27</a>, <a href="#R29" class="usa-link" aria-describedby="R29">29</a>, <a href="#R37" class="usa-link" aria-describedby="R37">37</a>]. The <em>BRCA</em> mutation rate in endometrioid carcinoma of the ovary is ≤ 10% [<a href="#R8" class="usa-link" aria-describedby="R8">8</a>, <a href="#R28" class="usa-link" aria-describedby="R28">28</a>, <a href="#R33" class="usa-link" aria-describedby="R33">33</a>, <a href="#R34" class="usa-link" aria-describedby="R34">34</a>]. Albeit less investigated, a similarly low frequency has been reported for clear cell carcinomas [<a href="#R25" class="usa-link" aria-describedby="R25">25</a>, <a href="#R26" class="usa-link" aria-describedby="R26">26</a>, <a href="#R28" class="usa-link" aria-describedby="R28">28</a>, <a href="#R34" class="usa-link" aria-describedby="R34">34</a>], a feature that may explain their generally poor response to platinum-based chemotherapy [<a href="#R38" class="usa-link" aria-describedby="R38">38</a>]. Here, we were unable to identify pathogenic <em>BRCA1/2</em> mutations in patients with endometrioid or clear cell carcinomas. However, we observed a potentially deleterious <em>BRCA2</em> germline variant (<em>BRCA2</em> p.S1946P) in two sisters with ovarian cancer (one with clear cell carcinoma and the other with serous carcinoma). The patients had a positive family history of malignancies (including pancreatic and colorectal cancer) known to be associated with <em>BRCA</em> mutations [<a href="#R39" class="usa-link" aria-describedby="R39">39</a>, <a href="#R40" class="usa-link" aria-describedby="R40">40</a>]. We initially reasoned that the malignancies of the two patients could have been caused by the Lynch syndrome [<a href="#R41" class="usa-link" aria-describedby="R41">41</a>] or mutations in <em>TP53</em> or other DNA repair genes [<a href="#R42" class="usa-link" aria-describedby="R42">42</a>–<a href="#R44" class="usa-link" aria-describedby="R44">44</a>]. However, both sisters did not show any shared pathogenic variant in 29 DNA repair genes (including <em>TP53, MLH1, MSH2, MSH6</em>, <em>PMS2</em> and genes involved in homologous recombination). Moreover, the change from serine to proline may affect protein conformational changes locally or globally and change protein functions [<a href="#R45" class="usa-link" aria-describedby="R45">45</a>]. pS1946P is located in exon 11 where the BRC motif binds to RAD51 and belongs to the ovarian cancer cluster region (OCCR). Mutations in this region have been shown to confer a higher risk for ovarian cancer [<a href="#R46" class="usa-link" aria-describedby="R46">46</a>, <a href="#R47" class="usa-link" aria-describedby="R47">47</a>]. Taken together, our data suggest that the VUS <em>BRCA2</em> p.S1946P may be pathogenic.</p>
<section class="tw xbox font-sm" id="T4"><h3 class="obj_head">Table 4. Prevalence of germline and somatic <em>BRCA1/2</em> mutations in ovarian cancer.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<thead><tr>
<th align="left" valign="middle" rowspan="1" colspan="1">Authors</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Samples</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Somatic plus germline % (n/N)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Somatic only % (n/N)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">Analytical method</th>
</tr></thead>
<tbody>
<tr><td align="left" valign="middle" colspan="5" rowspan="1">
<strong>High-grade serous ovarian carcinomas</strong>
</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Mafficini, 2016 [
]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">FFPE</td>
<td align="center" valign="middle" rowspan="1" colspan="1">28 (13/47)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">23 (3/13)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NGS (Ion Torrent)</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">McAlpine, 2012 [
]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Fresh</td>
<td align="center" valign="middle" rowspan="1" colspan="1">30 (31/103)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">16 (5/31)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Illumina exome sequencing, DHPLC (part), MLPA</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">TCGA, 2011 [
]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Fresh</td>
<td align="center" valign="middle" rowspan="1" colspan="1">22 (70/316)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">27 (19/70)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NGS</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Hennessy, 2010 [
]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Fresh</td>
<td align="center" valign="middle" rowspan="1" colspan="1">19 (44/235)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">39 (11/28)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Agilent high-density tiling array</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Current study</td>
<td align="center" valign="middle" rowspan="1" colspan="1">FFPE</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26 (12/46)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">33 (4/12)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NGS (Ion Torrent)</td>
</tr>
<tr><td align="left" valign="middle" colspan="5" rowspan="1">
<strong>High-grade serous and non-serous ovarian carcinomas</strong>
</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Hilton, 2002 [
]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Fresh</td>
<td align="center" valign="middle" rowspan="1" colspan="1">33 (30/92)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">40 (12/30)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PTT</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Current study</td>
<td align="center" valign="middle" rowspan="1" colspan="1">FFPE</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12 (12/99)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">33 (4/12)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NGS (Ion Torrent)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p36"><p>Abbreviations: FFPE, formalin-fixed paraffin-embedded; DHPLC, denaturing high-performance liquid chromatography; MLPA, multiplex ligation-dependent probe amplification; NGS, next-generation sequencing; PTT, protein truncation test; TCGA, The Cancer Genome Atlas Research Network.</p></div></div></section><p>We then analyzed the eligibility for PARPi of the 14 patients who carried either pathogenic <em>BRCA1/2</em> mutations or the <em>BRCA2</em> VUS p.S1946P. Only 10 patients (71.4%) met the FDA criteria for use of PARPi (owing to the presence of germline mutations), whereas all of them should have been eligible according to the EMA guidelines. Biallelic <em>BRCA1/2</em> inactivation was also considered, because tumor cells with monoallelic <em>BRCA</em> inactivation are unresponsive to PARPi [<a href="#R20" class="usa-link" aria-describedby="R20">20</a>]. In our study, <em>BRCA1/2</em> inactivation was identified in most – but not all – patients with pathogenic or potentially deleterious <em>BRCA</em> variants. However, an accurate estimation of the proportion of patients carrying monoallelic <em>BRCA1/2</em> inactivation was unfeasible because of the small sample size.</p>
<p>There were several limitations in our study. First, we did not analyze whether <em>BRCA1/2</em> genes were inactivated by epigenetic silencing [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>]. Second, other genes associated with homologous recombination deficiency in patients with ovarian cancer patients were not analyzed [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R10" class="usa-link" aria-describedby="R10">10</a>]. Consequently, we cannot exclude that the proportion of patients eligible for treatment with PARP inhibitors may have been underestimated. Third, the sample size of this study is small especially in the group of serous carcinoma. However, we provide the mutation rates in the understudied East Asian region, where we showed similar mutation rates to those reported in Caucasians and other ethnic subgroups. Fourth, the family history of each studied case was only retrieved from charts. Of note, none of the germline <em>BRCA1/2</em> had a family history of breast and ovarian cancer. Careful cancer screening on the family members of any detected pathogenic germline <em>BRCA1/2</em> mutation should be advised.</p>
<p>In conclusion, <em>BRCA1/2</em> mutations are common in Taiwanese patients with serous ovarian carcinoma. Several novel <em>BRCA1/2</em> mutations reported herein warrant further validation for their pathogenic potentials. The identification of <em>BRCA1/2</em> somatic mutations may have implications for guiding therapeutic decisions in patients with ovarian cancer.</p></section><section id="s4"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="s4_1"><h3 class="pmc_sec_title">Patients</h3>
<p>The study protocol was approved by the Institutional Review Board of the Chang Gung Memorial Hospital (IRB No. 104-6241B). Ninety-nine patients with ovarian cancer were included. The histological variants included serous (n = 46), endometrioid (n = 24), and clear cell (n = 29) carcinomas. The occurrence of breast and ovarian cancer in first- and second-degree relatives was investigated.</p></section><section id="s4_2"><h3 class="pmc_sec_title">Samples and DNA extraction</h3>
<p>We used FFPE samples obtained by surgical removal of the primary tumors. Normal FFPE samples were used as paired controls for specimens carrying genetic variants. Genomic DNA was isolated from two 10 μm-thick FFPE sections using the QIAamp DNA FFPE Tissue Kit (Qiagen, Hilden, Germany). We obtained blood samples from the family members of the two sisters harboring the <em>BRCA2</em> VUS p.S1946P. Genomic DNA was extracted from blood white cells using the QIAamp DNA Blood Midi Kit (Qiagen). The concentration and integrity of the purified DNA were checked using the Quanti-iT dsDNA HS Assay (Invitrogen, Carlsbad, CA, USA) and a Fragment Analyzer (Advanced Analytical Technologies, Ankeny, IA, USA), respectively.</p></section><section id="s4_3"><h3 class="pmc_sec_title">
<em>BRCA1/2</em> sequencing and data processing</h3>
<p>Genomic DNA (40 ng) was amplified using 250 primer pairs (GeneRead DNASeq Targeted panels v2, Qiagen) to target all of the exonic regions as well as the intronic regions within 20-bp of a splicing junction. Amplicons were ligated to a barcode adaptor using the Ion Xpress™ Plus Fragment Library Kit (Life Technologies, Carlsbad, CA, USA). The barcoded library was then enriched by emulsion PCR using OneTouch2 and OneTouch ES instruments (Life Technologies) following the Ion Torrent protocol provided by Life Technologies. The library's quantity and quality were examined on a fragment analyzer (Advanced Analytical Technologies) and a Qubit fluorometer (Invitrogen). The enriched library was sequenced using the Ion Personal Genome Machine (PGM) with an Ion 318 chip (Life Technologies) following the manufacturer's instructions. The mean sequencing depth for FFPE tumor samples was &gt;5700×, with a mean uniformity of 91.1%. Variants with a frequency &gt;10% were confirmed by Sanger sequencing of tumor DNA. Germline DNA was analyzed by NGS or Sanger sequencing. Germline DNA from the siblings of the two sisters carrying the <em>BRCA2</em> VUS p.S1946P was also examined by Sanger sequencing.</p></section><section id="s4_4"><h3 class="pmc_sec_title">Analysis of genetic variants</h3>
<p>Raw sequence data were mapped to the human reference genome (hg19) using The Torrent Suite Server (v. 4.2). Variant calling was performed with the Torrent Suite Variant Caller plug-in (v. 4.2) and the Variant Effect Predictor (VEP) was used for annotation. Variants with a read count &lt;25 and a variant frequency &lt;5% were not analyzed further. Common single nucleotide polymorphisms (SNPs) were identified using the dbSNP (release 138), 1000 Genome (phase 1 data), and 5000 Exome data sets. Previously reported <em>BRCA1/2</em> mutations were identified and classified with the BIC (Breast Cancer Information Core, <a href="http://research.nhgri.nih.gov/bic/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://research.nhgri.nih.gov/bic/</a>), ClinVar (<a href="http://www.ncbi.nlm.nih.gov/clinvar/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.ncbi.nlm.nih.gov/clinvar/</a>), LOVD (Leiden Open Variation Database, <a href="http://www.lovd.nl/3.0/home" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.lovd.nl/3.0/home</a>), ARUP (<a href="http://arup.utah.edu/database/BRCA/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://arup.utah.edu/database/BRCA/</a>), and BRCA Share (<a href="http://www.umd.be/BRCA1/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.umd.be/BRCA1/</a>) data sets. A variant classified as “likely benign” or “likely pathogenic” by the ClinVar was considered as VUS. Variants were classified as pathogenic if 1) they were labeled as such in any of the data sets used for the study or 2) they were frameshift or stop mutations. Variants were considered as benign if they were unequivocally classified as such (i.e., without a concurrent classification either as VUS or pathogenic within the same database) in the consulted data sets. All of the previously unidentified variants that were not clearly benign or pathogenic were regarded as VUS. A pathogenic variant was considered as novel if it was absent in the abovementioned data sets as well as in the COSMIC database (version 70, <a href="http://cancer.sanger.ac.uk/cosmic" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://cancer.sanger.ac.uk/cosmic</a>). SIFT (<a href="http://sift.jcvi.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://sift.jcvi.org/</a>), PolyPhen2 (<a href="http://genetics.bwh.harvard.edu/pph2/index.shtml" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://genetics.bwh.harvard.edu/pph2/index.shtml</a>), and Grantham (<a href="http://asia.ensembl.org/info/genome/variation/predicted_data.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://asia.ensembl.org/info/genome/variation/predicted_data.html</a>) were used to predict the functional impact of the detected variants (<a href="#SD1" class="usa-link">Supplementary Table S2</a>). Variants classified as “probably damaging” in PolyPhen2 were considered as pathogenic, whereas “possibly damaging” variants were classified as VUS. SNP data of 997 healthy subjects of the population-based project in Taiwan were downloaded for comparison (<a href="https://taiwanview.twbiobank.org.tw/index" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://taiwanview.twbiobank.org.tw/index</a>).</p>
<p>In line with previous methodology [<a href="#R48" class="usa-link" aria-describedby="R48">48</a>], LOH was determined by analyzing the frequency of the patient's SNPs within the mutated <em>BRCA</em> gene using the ADTEx tool. This method may also detect large genomic rearrangements.</p></section><section id="s4_5"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>Intergroup differences were analyzed using Fisher's exact tests, χ<sup>2</sup> tests, or Student's <em>t</em>-tests, as appropriate. All calculations were performed using the IBM SPSS software package (version 17.0; IBM, Armonk, NY, USA). P values &lt; 0.05 (two-tailed) were considered statistically significant.</p></section></section><section id="s5"><h2 class="pmc_sec_title">SUPPLEMENTARY MATERIALS FIGURES AND TABLES</h2>
<section class="sm xbox font-sm" id="SD1"><div class="media p" id="d35e2256"><div class="caption">
<a href="/articles/instance/5356755/bin/oncotarget-07-85529-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">oncotarget-07-85529-s001.pdf</a><sup> (2MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We are grateful to Chiao-Yun Lin, Yen-Jung Lu, and Jung-Erh Yang for their technical assistance.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>CONFLICTS OF INTEREST</strong></p>
<p>Shu-Jen Chen, Nina Lapke, and Chien-Hung Chen are employees of ACT Genomics, Co. Ltd.</p>
</div>
<div class="fn p" id="fn2">
<p><strong>GRANT SUPPORT</strong></p>
<p>This study was supported in part by the Chang Gung Medical Foundation (grants CMRPG3E0391/2/3 and CMRPG3B0063 to A. Chao, CMRPG3c0941/2/3 to T. H. Wang).</p>
</div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Department of Health, the Executive Yuan. Cancer registration annual report in Taiwan. 2014. </cite>
</li>
<li id="R2">
<span class="label">2.</span><cite>Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi: 10.3322/caac.21262.</cite> [<a href="https://doi.org/10.3322/caac.21262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25651787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Global%20cancer%20statistics,%202012&amp;author=LA%20Torre&amp;author=F%20Bray&amp;author=RL%20Siegel&amp;author=J%20Ferlay&amp;author=J%20Lortet-Tieulent&amp;volume=65&amp;publication_year=2015&amp;pages=87-108&amp;pmid=25651787&amp;doi=10.3322/caac.21262&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. doi: 10.3322/caac.21254.</cite> [<a href="https://doi.org/10.3322/caac.21254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25559415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Cancer%20statistics,%202015&amp;author=RL%20Siegel&amp;author=KD%20Miller&amp;author=A%20Jemal&amp;volume=65&amp;publication_year=2015&amp;pages=5-29&amp;pmid=25559415&amp;doi=10.3322/caac.21254&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Modesitt SC, Jazaeri AA. Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics. Expert Opin Pharmacother. 2007;8:2293–2305. doi: 10.1517/14656566.8.14.2293.</cite> [<a href="https://doi.org/10.1517/14656566.8.14.2293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17927484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Pharmacother&amp;title=Recurrent%20epithelial%20ovarian%20cancer:%20pharmacotherapy%20and%20novel%20therapeutics&amp;author=SC%20Modesitt&amp;author=AA%20Jazaeri&amp;volume=8&amp;publication_year=2007&amp;pages=2293-2305&amp;pmid=17927484&amp;doi=10.1517/14656566.8.14.2293&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–615. doi: 10.1038/nature10166.</cite> [<a href="https://doi.org/10.1038/nature10166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3163504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21720365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Integrated%20genomic%20analyses%20of%20ovarian%20carcinoma&amp;volume=474&amp;publication_year=2011&amp;pages=609-615&amp;pmid=21720365&amp;doi=10.1038/nature10166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Hennessy BT, Timms KM, Carey MS, Gutin A, Meyer LA, Flake DD, 2nd, Abkevich V, Potter J, Pruss D, Glenn P, Li Y, Li J, et al.  Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer. J Clin Oncol. 2010;28:3570–3576. doi: 10.1200/JCO.2009.27.2997.</cite> [<a href="https://doi.org/10.1200/JCO.2009.27.2997" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2917312/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20606085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Somatic%20mutations%20in%20BRCA1%20and%20BRCA2%20could%20expand%20the%20number%20of%20patients%20that%20benefit%20from%20poly%20(ADP%20ribose)%20polymerase%20inhibitors%20in%20ovarian%20cancer&amp;author=BT%20Hennessy&amp;author=KM%20Timms&amp;author=MS%20Carey&amp;author=A%20Gutin&amp;author=LA%20Meyer&amp;volume=28&amp;publication_year=2010&amp;pages=3570-3576&amp;pmid=20606085&amp;doi=10.1200/JCO.2009.27.2997&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Yang D, Khan S, Sun Y, Hess K, Shmulevich I, Sood AK, Zhang W. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA. 2011;306:1557–1565. doi: 10.1001/jama.2011.1456.</cite> [<a href="https://doi.org/10.1001/jama.2011.1456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4159096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21990299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association%20of%20BRCA1%20and%20BRCA2%20mutations%20with%20survival,%20chemotherapy%20sensitivity,%20and%20gene%20mutator%20phenotype%20in%20patients%20with%20ovarian%20cancer&amp;author=D%20Yang&amp;author=S%20Khan&amp;author=Y%20Sun&amp;author=K%20Hess&amp;author=I%20Shmulevich&amp;volume=306&amp;publication_year=2011&amp;pages=1557-1565&amp;pmid=21990299&amp;doi=10.1001/jama.2011.1456&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, Dobrovic A, Birrer MJ, Webb PM, Stewart C, Friedlander M, Fox S, et al.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012;30:2654–2663. doi: 10.1200/JCO.2011.39.8545.</cite> [<a href="https://doi.org/10.1200/JCO.2011.39.8545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3413277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22711857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=BRCA%20mutation%20frequency%20and%20patterns%20of%20treatment%20response%20in%20BRCA%20mutation-positive%20women%20with%20ovarian%20cancer:%20a%20report%20from%20the%20Australian%20Ovarian%20Cancer%20Study%20Group&amp;author=K%20Alsop&amp;author=S%20Fereday&amp;author=C%20Meldrum&amp;author=A%20deFazio&amp;author=C%20Emmanuel&amp;volume=30&amp;publication_year=2012&amp;pages=2654-2663&amp;pmid=22711857&amp;doi=10.1200/JCO.2011.39.8545&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, et al.  Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA. 2012;307:382–390. doi: 10.1001/jama.2012.20.</cite> [<a href="https://doi.org/10.1001/jama.2012.20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3727895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22274685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association%20between%20BRCA1%20and%20BRCA2%20mutations%20and%20survival%20in%20women%20with%20invasive%20epithelial%20ovarian%20cancer&amp;author=KL%20Bolton&amp;author=G%20Chenevix-Trench&amp;author=C%20Goh&amp;author=S%20Sadetzki&amp;author=SJ%20Ramus&amp;volume=307&amp;publication_year=2012&amp;pages=382-390&amp;pmid=22274685&amp;doi=10.1001/jama.2012.20&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH, Thornton A, Norquist BM, Casadei S, Nord AS, Agnew KJ, Pritchard CC, et al.  Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res. 2014;20:764–775. doi: 10.1158/1078-0432.CCR-13-2287.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-13-2287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3944197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24240112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Germline%20and%20somatic%20mutations%20in%20homologous%20recombination%20genes%20predict%20platinum%20response%20and%20survival%20in%20ovarian,%20fallopian%20tube,%20and%20peritoneal%20carcinomas&amp;author=KP%20Pennington&amp;author=T%20Walsh&amp;author=MI%20Harrell&amp;author=MK%20Lee&amp;author=CC%20Pennil&amp;volume=20&amp;publication_year=2014&amp;pages=764-775&amp;pmid=24240112&amp;doi=10.1158/1078-0432.CCR-13-2287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Nielsen FC, van Overeem Hansen T, Sorensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer. 2016. </cite> [<a href="https://doi.org/10.1038/nrc.2016.72" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27515922/" class="usa-link">PubMed</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Dann RB, DeLoia JA, Timms KM, Zorn KK, Potter J, Flake DD, 2nd, Lanchbury JS, Krivak TC. BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol. 2012;125:677–682. doi: 10.1016/j.ygyno.2012.03.006.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2012.03.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22406760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=BRCA1/2%20mutations%20and%20expression:%20response%20to%20platinum%20chemotherapy%20in%20patients%20with%20advanced%20stage%20epithelial%20ovarian%20cancer&amp;author=RB%20Dann&amp;author=JA%20DeLoia&amp;author=KM%20Timms&amp;author=KK%20Zorn&amp;author=J%20Potter&amp;volume=125&amp;publication_year=2012&amp;pages=677-682&amp;pmid=22406760&amp;doi=10.1016/j.ygyno.2012.03.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott CL, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, et al.  Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol. 2014;15:852–861. doi: 10.1016/S1470-2045(14)70228-1.</cite> [<a href="https://doi.org/10.1016/S1470-2045(14)70228-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24882434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Olaparib%20maintenance%20therapy%20in%20patients%20with%20platinum-sensitive%20relapsed%20serous%20ovarian%20cancer:%20a%20preplanned%20retrospective%20analysis%20of%20outcomes%20by%20BRCA%20status%20in%20a%20randomised%20phase%202%20trial&amp;author=J%20Ledermann&amp;author=P%20Harter&amp;author=C%20Gourley&amp;author=M%20Friedlander&amp;author=I%20Vergote&amp;volume=15&amp;publication_year=2014&amp;pages=852-861&amp;pmid=24882434&amp;doi=10.1016/S1470-2045(14)70228-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Kaufman B, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmana J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, Steiner M, et al.  Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J Clin Oncol. 2015;33:244–250. doi: 10.1200/JCO.2014.56.2728.</cite> [<a href="https://doi.org/10.1200/JCO.2014.56.2728" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6057749/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25366685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Olaparib%20monotherapy%20in%20patients%20with%20advanced%20cancer%20and%20a%20germline%20BRCA1/2%20mutation&amp;author=B%20Kaufman&amp;author=R%20Shapira-Frommer&amp;author=RK%20Schmutzler&amp;author=MW%20Audeh&amp;author=M%20Friedlander&amp;volume=33&amp;publication_year=2015&amp;pages=244-250&amp;pmid=25366685&amp;doi=10.1200/JCO.2014.56.2728&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Domchek SM, Aghajanian C, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmana J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, et al.  Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. Gynecol Oncol. 2016;140:199–203. doi: 10.1016/j.ygyno.2015.12.020.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2015.12.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4992984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26723501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Efficacy%20and%20safety%20of%20olaparib%20monotherapy%20in%20germline%20BRCA1/2%20mutation%20carriers%20with%20advanced%20ovarian%20cancer%20and%20three%20or%20more%20lines%20of%20prior%20therapy&amp;author=SM%20Domchek&amp;author=C%20Aghajanian&amp;author=R%20Shapira-Frommer&amp;author=RK%20Schmutzler&amp;author=MW%20Audeh&amp;volume=140&amp;publication_year=2016&amp;pages=199-203&amp;pmid=26723501&amp;doi=10.1016/j.ygyno.2015.12.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Macpherson E, et al.  Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med. 2012;366:1382–1392. doi: 10.1056/NEJMoa1105535.</cite> [<a href="https://doi.org/10.1056/NEJMoa1105535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22452356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Olaparib%20maintenance%20therapy%20in%20platinum-sensitive%20relapsed%20ovarian%20cancer&amp;author=J%20Ledermann&amp;author=P%20Harter&amp;author=C%20Gourley&amp;author=M%20Friedlander&amp;author=I%20Vergote&amp;volume=366&amp;publication_year=2012&amp;pages=1382-1392&amp;pmid=22452356&amp;doi=10.1056/NEJMoa1105535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Maxwell KN, Sloover DD, Wubbenhorst B, Wenz B, Lunceford N, Emery L, D'Andrea K, Daber RD, Feldman MD, Domchek SM, Nathanson KL. Abstract 2990: Evidence for diverse mechanisms of tumorigenesis in breast and ovarian tumors of BRCA1/2 carriers. Can Res. 2015. p. 75.</cite>
</li>
<li id="R18">
<span class="label">18.</span><cite>Sedic M, Skibinski A, Brown N, Gallardo M, Mulligan P, Martinez P, Keller PJ, Glover E, Richardson AL, Cowan J, Toland AE, Ravichandran K, et al.  Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence. Nat Commun. 2015;6:7505. doi: 10.1038/ncomms8505.</cite> [<a href="https://doi.org/10.1038/ncomms8505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4491827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26106036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Haploinsufficiency%20for%20BRCA1%20leads%20to%20cell-type-specific%20genomic%20instability%20and%20premature%20senescence&amp;author=M%20Sedic&amp;author=A%20Skibinski&amp;author=N%20Brown&amp;author=M%20Gallardo&amp;author=P%20Mulligan&amp;volume=6&amp;publication_year=2015&amp;pages=7505&amp;pmid=26106036&amp;doi=10.1038/ncomms8505&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Cousineau I, Belmaaza A. BRCA1 haploinsufficiency, but not heterozygosity for a BRCA1-truncating mutation, deregulates homologous recombination. Cell Cycle. 2007;6:962–971. doi: 10.4161/cc.6.8.4105.</cite> [<a href="https://doi.org/10.4161/cc.6.8.4105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17404506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Cycle&amp;title=BRCA1%20haploinsufficiency,%20but%20not%20heterozygosity%20for%20a%20BRCA1-truncating%20mutation,%20deregulates%20homologous%20recombination&amp;author=I%20Cousineau&amp;author=A%20Belmaaza&amp;volume=6&amp;publication_year=2007&amp;pages=962-971&amp;pmid=17404506&amp;doi=10.4161/cc.6.8.4105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, Ota A, Wong HY, Konishi Y, Karakas B, Tahir K, Abukhdeir AM, et al.  Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc Natl Acad Sci U S A. 2011;108:17773–17778. doi: 10.1073/pnas.1110969108.</cite> [<a href="https://doi.org/10.1073/pnas.1110969108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3203756/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21987798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Mutation%20of%20a%20single%20allele%20of%20the%20cancer%20susceptibility%20gene%20BRCA1%20leads%20to%20genomic%20instability%20in%20human%20breast%20epithelial%20cells&amp;author=H%20Konishi&amp;author=M%20Mohseni&amp;author=A%20Tamaki&amp;author=JP%20Garay&amp;author=S%20Croessmann&amp;volume=108&amp;publication_year=2011&amp;pages=17773-17778&amp;pmid=21987798&amp;doi=10.1073/pnas.1110969108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Wang PH, Shyong WY, Li YF, Lee HH, Tsai WY, Chao HT, Wu CY, Tsai YC, Yuan CC. BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serous peritoneal carcinoma. Jpn J Clin Oncol. 2000;30:343–348. doi: 10.1093/jjco/hyd092.</cite> [<a href="https://doi.org/10.1093/jjco/hyd092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11059339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jpn%20J%20Clin%20Oncol&amp;title=BRCA1%20mutations%20in%20Taiwanese%20with%20epithelial%20ovarian%20carcinoma%20and%20sporadic%20primary%20serous%20peritoneal%20carcinoma&amp;author=PH%20Wang&amp;author=WY%20Shyong&amp;author=YF%20Li&amp;author=HH%20Lee&amp;author=WY%20Tsai&amp;volume=30&amp;publication_year=2000&amp;pages=343-348&amp;pmid=11059339&amp;doi=10.1093/jjco/hyd092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Chao A, Lai CH, Tsai CL, Hsueh S, Hsueh C, Lin CY, Chou HH, Lin YJ, Chen HW, Chang TC, Wang TH. Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer. PLoS One. 2013;8:e57084. doi: 10.1371/journal.pone.0057084.</cite> [<a href="https://doi.org/10.1371/journal.pone.0057084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3584135/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23468915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Tumor%20stress-induced%20phosphoprotein1%20(STIP1)%20as%20a%20prognostic%20biomarker%20in%20ovarian%20cancer&amp;author=A%20Chao&amp;author=CH%20Lai&amp;author=CL%20Tsai&amp;author=S%20Hsueh&amp;author=C%20Hsueh&amp;volume=8&amp;publication_year=2013&amp;pages=e57084&amp;pmid=23468915&amp;doi=10.1371/journal.pone.0057084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>del Carmen MG, Birrer M, Schorge JO. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol. 2012;126:481–490. doi: 10.1016/j.ygyno.2012.04.021.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2012.04.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22525820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Clear%20cell%20carcinoma%20of%20the%20ovary:%20a%20review%20of%20the%20literature&amp;author=MG%20del%20Carmen&amp;author=M%20Birrer&amp;author=JO%20Schorge&amp;volume=126&amp;publication_year=2012&amp;pages=481-490&amp;pmid=22525820&amp;doi=10.1016/j.ygyno.2012.04.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Chiang YC, Chen CA, Chiang CJ, Hsu TH, Lin MC, You SL, Cheng WF, Lai MS. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol. 2013;24:342–351. doi: 10.3802/jgo.2013.24.4.342.</cite> [<a href="https://doi.org/10.3802/jgo.2013.24.4.342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3805915/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24167670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Gynecol%20Oncol&amp;title=Trends%20in%20incidence%20and%20survival%20outcome%20of%20epithelial%20ovarian%20cancer:%2030-year%20national%20population-based%20registry%20in%20Taiwan&amp;author=YC%20Chiang&amp;author=CA%20Chen&amp;author=CJ%20Chiang&amp;author=TH%20Hsu&amp;author=MC%20Lin&amp;volume=24&amp;publication_year=2013&amp;pages=342-351&amp;pmid=24167670&amp;doi=10.3802/jgo.2013.24.4.342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JG, Meijers-Heijboer H, Radice P, et al.  Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res. 2004;10:2473–2481. doi: 10.1158/1078-0432.ccr-1029-3.</cite> [<a href="https://doi.org/10.1158/1078-0432.ccr-1029-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15073127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Pathology%20of%20ovarian%20cancers%20in%20BRCA1%20and%20BRCA2%20carriers&amp;author=SR%20Lakhani&amp;author=S%20Manek&amp;author=F%20Penault-Llorca&amp;author=A%20Flanagan&amp;author=L%20Arnout&amp;volume=10&amp;publication_year=2004&amp;pages=2473-2481&amp;pmid=15073127&amp;doi=10.1158/1078-0432.ccr-1029-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Goodheart MJ, Rose SL, Hattermann-Zogg M, Smith BJ, De Young BR, Buller RE. BRCA2 alteration is important in clear cell carcinoma of the ovary. Clin Genet. 2009;76:161–167. doi: 10.1111/j.1399-0004.2009.01207.x.</cite> [<a href="https://doi.org/10.1111/j.1399-0004.2009.01207.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19656163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Genet&amp;title=BRCA2%20alteration%20is%20important%20in%20clear%20cell%20carcinoma%20of%20the%20ovary&amp;author=MJ%20Goodheart&amp;author=SL%20Rose&amp;author=M%20Hattermann-Zogg&amp;author=BJ%20Smith&amp;author=BR%20De%20Young&amp;volume=76&amp;publication_year=2009&amp;pages=161-167&amp;pmid=19656163&amp;doi=10.1111/j.1399-0004.2009.01207.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>McAlpine JN, Porter H, Kobel M, Nelson BH, Prentice LM, Kalloger SE, Senz J, Milne K, Ding J, Shah SP, Huntsman DG, Gilks CB. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. Mod Pathol. 2012;25:740–750. doi: 10.1038/modpathol.2011.211.</cite> [<a href="https://doi.org/10.1038/modpathol.2011.211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22282309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mod%20Pathol&amp;title=BRCA1%20and%20BRCA2%20mutations%20correlate%20with%20TP53%20abnormalities%20and%20presence%20of%20immune%20cell%20infiltrates%20in%20ovarian%20high-grade%20serous%20carcinoma&amp;author=JN%20McAlpine&amp;author=H%20Porter&amp;author=M%20Kobel&amp;author=BH%20Nelson&amp;author=LM%20Prentice&amp;volume=25&amp;publication_year=2012&amp;pages=740-750&amp;pmid=22282309&amp;doi=10.1038/modpathol.2011.211&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Sakamoto I, Hirotsu Y, Nakagomi H, Ouchi H, Ikegami A, Teramoto K, Amemiya K, Mochizuki H, Omata M. BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer. Cancer. 2016;122:84–90. doi: 10.1002/cncr.29707.</cite> [<a href="https://doi.org/10.1002/cncr.29707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26439132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=BRCA1%20and%20BRCA2%20mutations%20in%20Japanese%20patients%20with%20ovarian,%20fallopian%20tube,%20and%20primary%20peritoneal%20cancer&amp;author=I%20Sakamoto&amp;author=Y%20Hirotsu&amp;author=H%20Nakagomi&amp;author=H%20Ouchi&amp;author=A%20Ikegami&amp;volume=122&amp;publication_year=2016&amp;pages=84-90&amp;pmid=26439132&amp;doi=10.1002/cncr.29707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Mafficini A, Simbolo M, Parisi A, Rusev B, Luchini C, Cataldo I, Piazzola E, Sperandio N, Turri G, Franchi M, Tortora G, Bovo C, et al.  BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing. Oncotarget. 2016;7:1076–1083. doi: 10.18632/oncotarget.6834.</cite> [<a href="https://doi.org/10.18632/oncotarget.6834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4811444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26745875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=BRCA%20somatic%20and%20germline%20mutation%20detection%20in%20paraffin%20embedded%20ovarian%20cancers%20by%20next-generation%20sequencing&amp;author=A%20Mafficini&amp;author=M%20Simbolo&amp;author=A%20Parisi&amp;author=B%20Rusev&amp;author=C%20Luchini&amp;volume=7&amp;publication_year=2016&amp;pages=1076-1083&amp;pmid=26745875&amp;doi=10.18632/oncotarget.6834&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480–1490. doi: 10.1200/JCO.2002.20.6.1480.</cite> [<a href="https://doi.org/10.1200/JCO.2002.20.6.1480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11896095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Clinical%20characteristics%20of%20individuals%20with%20germline%20mutations%20in%20BRCA1%20and%20BRCA2:%20analysis%20of%2010,000%20individuals&amp;author=TS%20Frank&amp;author=AM%20Deffenbaugh&amp;author=JE%20Reid&amp;author=M%20Hulick&amp;author=BE%20Ward&amp;volume=20&amp;publication_year=2002&amp;pages=1480-1490&amp;pmid=11896095&amp;doi=10.1200/JCO.2002.20.6.1480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Kim YC, Zhao L, Zhang H, Huang Y, Cui J, Xiao F, Downs B, Wang SM. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients. Oncotarget. 2016;7:9600–9612. doi: 10.18632/oncotarget.7144.</cite> [<a href="https://doi.org/10.18632/oncotarget.7144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4891063/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26848529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Prevalence%20and%20spectrum%20of%20BRCA%20germline%20variants%20in%20mainland%20Chinese%20familial%20breast%20and%20ovarian%20cancer%20patients&amp;author=YC%20Kim&amp;author=L%20Zhao&amp;author=H%20Zhang&amp;author=Y%20Huang&amp;author=J%20Cui&amp;volume=7&amp;publication_year=2016&amp;pages=9600-9612&amp;pmid=26848529&amp;doi=10.18632/oncotarget.7144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Kurman RJ, Carcangiu M.L., Herrington C.S., Young R.H. International Agency for Research on Cancer. 4. 2014. </cite>
</li>
<li id="R33">
<span class="label">33.</span><cite>Hasmad HN, Lai KN, Wen WX, Park DJ, Nguyen-Dumont T, Kang PC, Thirthagiri E, Ma'som M, Lim BK, Southey M, Woo YL, Teo SH. Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients. Gynecol Oncol. 2016;141:318–322. doi: 10.1016/j.ygyno.2015.11.001.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2015.11.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26541979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol%20Oncol&amp;title=Evaluation%20of%20germline%20BRCA1%20and%20BRCA2%20mutations%20in%20a%20multi-ethnic%20Asian%20cohort%20of%20ovarian%20cancer%20patients&amp;author=HN%20Hasmad&amp;author=KN%20Lai&amp;author=WX%20Wen&amp;author=DJ%20Park&amp;author=T%20Nguyen-Dumont&amp;volume=141&amp;publication_year=2016&amp;pages=318-322&amp;pmid=26541979&amp;doi=10.1016/j.ygyno.2015.11.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, et al.  BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 2005;104:2807–2816. doi: 10.1002/cncr.21536.</cite> [<a href="https://doi.org/10.1002/cncr.21536" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16284991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=BRCA1%20and%20BRCA2%20mutations%20account%20for%20a%20large%20proportion%20of%20ovarian%20carcinoma%20cases&amp;author=T%20Pal&amp;author=J%20Permuth-Wey&amp;author=JA%20Betts&amp;author=JP%20Krischer&amp;author=J%20Fiorica&amp;volume=104&amp;publication_year=2005&amp;pages=2807-2816&amp;pmid=16284991&amp;doi=10.1002/cncr.21536&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98:1694–1706. doi: 10.1093/jnci/djj465.</cite> [<a href="https://doi.org/10.1093/jnci/djj465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17148771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Cancer%20Inst&amp;title=Population%20BRCA1%20and%20BRCA2%20mutation%20frequencies%20and%20cancer%20penetrances:%20a%20kin-cohort%20study%20in%20Ontario,%20Canada&amp;author=HA%20Risch&amp;author=JR%20McLaughlin&amp;author=DE%20Cole&amp;author=B%20Rosen&amp;author=L%20Bradley&amp;volume=98&amp;publication_year=2006&amp;pages=1694-1706&amp;pmid=17148771&amp;doi=10.1093/jnci/djj465&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Choi MC, Heo JH, Jang JH, Jung SG, Park H, Joo WD, Lee C, Lee JH, Lee JM, Hwang YY, Kim SJ. Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations. Int J Gynecol Cancer. 2015;25:1386–1391. doi: 10.1097/IGC.0000000000000529.</cite> [<a href="https://doi.org/10.1097/IGC.0000000000000529" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26402875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Gynecol%20Cancer&amp;title=Germline%20Mutations%20of%20BRCA1%20and%20BRCA2%20in%20Korean%20Ovarian%20Cancer%20Patients:%20Finding%20Founder%20Mutations&amp;author=MC%20Choi&amp;author=JH%20Heo&amp;author=JH%20Jang&amp;author=SG%20Jung&amp;author=H%20Park&amp;volume=25&amp;publication_year=2015&amp;pages=1386-1391&amp;pmid=26402875&amp;doi=10.1097/IGC.0000000000000529&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Hilton JL, Geisler JP, Rathe JA, Hattermann-Zogg MA, DeYoung B, Buller RE. Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst. 2002;94:1396–1406. doi: 10.1093/jnci/94.18.1396.</cite> [<a href="https://doi.org/10.1093/jnci/94.18.1396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12237285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Cancer%20Inst&amp;title=Inactivation%20of%20BRCA1%20and%20BRCA2%20in%20ovarian%20cancer&amp;author=JL%20Hilton&amp;author=JP%20Geisler&amp;author=JA%20Rathe&amp;author=MA%20Hattermann-Zogg&amp;author=B%20DeYoung&amp;volume=94&amp;publication_year=2002&amp;pages=1396-1406&amp;pmid=12237285&amp;doi=10.1093/jnci/94.18.1396&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T, Suzuki M, Sato I, Taguchi K. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer. 2000;88:2584–2589.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10861437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Clinical%20characteristics%20of%20clear%20cell%20carcinoma%20of%20the%20ovary:%20a%20distinct%20histologic%20type%20with%20poor%20prognosis%20and%20resistance%20to%20platinum-based%20chemotherapy&amp;author=T%20Sugiyama&amp;author=T%20Kamura&amp;author=J%20Kigawa&amp;author=N%20Terakawa&amp;author=Y%20Kikuchi&amp;volume=88&amp;publication_year=2000&amp;pages=2584-2589&amp;pmid=10861437&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Couch FJ, Johnson MR, Rabe KG, Brune K, de Andrade M, Goggins M, Rothenmund H, Gallinger S, Klein A, Petersen GM, Hruban RH. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:342–346. doi: 10.1158/1055-9965.EPI-06-0783.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-06-0783" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17301269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=The%20prevalence%20of%20BRCA2%20mutations%20in%20familial%20pancreatic%20cancer&amp;author=FJ%20Couch&amp;author=MR%20Johnson&amp;author=KG%20Rabe&amp;author=K%20Brune&amp;author=M%20de%20Andrade&amp;volume=16&amp;publication_year=2007&amp;pages=342-346&amp;pmid=17301269&amp;doi=10.1158/1055-9965.EPI-06-0783&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Phelan CM, Iqbal J, Lynch HT, Lubinski J, Gronwald J, Moller P, Ghadirian P, Foulkes WD, Armel S, Eisen A, Neuhausen SL, Senter L, et al.  Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study. Br J Cancer. 2014;110:530–534. doi: 10.1038/bjc.2013.741.</cite> [<a href="https://doi.org/10.1038/bjc.2013.741" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3899769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24292448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&amp;title=Incidence%20of%20colorectal%20cancer%20in%20BRCA1%20and%20BRCA2%20mutation%20carriers:%20results%20from%20a%20follow-up%20study&amp;author=CM%20Phelan&amp;author=J%20Iqbal&amp;author=HT%20Lynch&amp;author=J%20Lubinski&amp;author=J%20Gronwald&amp;volume=110&amp;publication_year=2014&amp;pages=530-534&amp;pmid=24292448&amp;doi=10.1038/bjc.2013.741&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R41">
<span class="label">41.</span><cite>Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer) N Engl J Med. 2005;352:1851–1860. doi: 10.1056/NEJMoa043146.</cite> [<a href="https://doi.org/10.1056/NEJMoa043146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15872200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Screening%20for%20the%20Lynch%20syndrome%20(hereditary%20nonpolyposis%20colorectal%20cancer)&amp;author=H%20Hampel&amp;author=WL%20Frankel&amp;author=E%20Martin&amp;author=M%20Arnold&amp;author=K%20Khanduja&amp;volume=352&amp;publication_year=2005&amp;pages=1851-1860&amp;pmid=15872200&amp;doi=10.1056/NEJMoa043146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R42">
<span class="label">42.</span><cite>Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, et al.  TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet. 2010;47:421–428. doi: 10.1136/jmg.2009.073429.</cite> [<a href="https://doi.org/10.1136/jmg.2009.073429" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20522432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=TP53%20germline%20mutation%20testing%20in%20180%20families%20suspected%20of%20Li-Fraumeni%20syndrome:%20mutation%20detection%20rate%20and%20relative%20frequency%20of%20cancers%20in%20different%20familial%20phenotypes&amp;author=MW%20Ruijs&amp;author=S%20Verhoef&amp;author=MA%20Rookus&amp;author=R%20Pruntel&amp;author=AH%20van%20der%20Hout&amp;volume=47&amp;publication_year=2010&amp;pages=421-428&amp;pmid=20522432&amp;doi=10.1136/jmg.2009.073429&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R43">
<span class="label">43.</span><cite>Hirasawa A, Masuda K, Akahane T, Ueki A, Yokota M, Tsuruta T, Nomura H, Kataoka F, Tominaga E, Banno K, Makita K, Susumu N, et al.  Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case. Jpn J Clin Oncol. 2014;44:49–56. doi: 10.1093/jjco/hyt171.</cite> [<a href="https://doi.org/10.1093/jjco/hyt171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24218521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jpn%20J%20Clin%20Oncol&amp;title=Family%20history%20and%20BRCA1/BRCA2%20status%20among%20Japanese%20ovarian%20cancer%20patients%20and%20occult%20cancer%20in%20a%20BRCA1%20mutant%20case&amp;author=A%20Hirasawa&amp;author=K%20Masuda&amp;author=T%20Akahane&amp;author=A%20Ueki&amp;author=M%20Yokota&amp;volume=44&amp;publication_year=2014&amp;pages=49-56&amp;pmid=24218521&amp;doi=10.1093/jjco/hyt171&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R44">
<span class="label">44.</span><cite>Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, Gulsuner S, Bernards SS, Casadei S, Yi Q, Burger RA, Chan JK, Davidson SA, et al.  Inherited Mutations in Women With Ovarian Carcinoma. JAMA Oncol. 2015. pp. 1–9.</cite> [<a href="https://doi.org/10.1001/jamaoncol.2015.5495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4845939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26720728/" class="usa-link">PubMed</a>]</li>
<li id="R45">
<span class="label">45.</span><cite>Williamson MP. The structure and function of proline-rich regions in proteins. Biochem J. 1994;297:249–260. doi: 10.1042/bj2970249.</cite> [<a href="https://doi.org/10.1042/bj2970249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1137821/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8297327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20J&amp;title=The%20structure%20and%20function%20of%20proline-rich%20regions%20in%20proteins&amp;author=MP%20Williamson&amp;volume=297&amp;publication_year=1994&amp;pages=249-260&amp;pmid=8297327&amp;doi=10.1042/bj2970249&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R46">
<span class="label">46.</span><cite>Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Consortium C, et al.  Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313:1347–1361. doi: 10.1001/jama.2014.5985.</cite> [<a href="https://doi.org/10.1001/jama.2014.5985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4537700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25849179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association%20of%20type%20and%20location%20of%20BRCA1%20and%20BRCA2%20mutations%20with%20risk%20of%20breast%20and%20ovarian%20cancer&amp;author=TR%20Rebbeck&amp;author=N%20Mitra&amp;author=F%20Wan&amp;author=OM%20Sinilnikova&amp;author=S%20Healey&amp;volume=313&amp;publication_year=2015&amp;pages=1347-1361&amp;pmid=25849179&amp;doi=10.1001/jama.2014.5985&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R47">
<span class="label">47.</span><cite>Narod SA. Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer. 2002;2:113–123. doi: 10.1038/nrc726.</cite> [<a href="https://doi.org/10.1038/nrc726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12635174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Modifiers%20of%20risk%20of%20hereditary%20breast%20and%20ovarian%20cancer&amp;author=SA%20Narod&amp;volume=2&amp;publication_year=2002&amp;pages=113-123&amp;pmid=12635174&amp;doi=10.1038/nrc726&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R48">
<span class="label">48.</span><cite>Amarasinghe KC, Li J, Hunter SM, Ryland GL, Cowin PA, Campbell IG, Halgamuge SK. Inferring copy number and genotype in tumour exome data. BMC Genomics. 2014;15:732. doi: 10.1186/1471-2164-15-732.</cite> [<a href="https://doi.org/10.1186/1471-2164-15-732" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4162913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25167919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Genomics&amp;title=Inferring%20copy%20number%20and%20genotype%20in%20tumour%20exome%20data&amp;author=KC%20Amarasinghe&amp;author=J%20Li&amp;author=SM%20Hunter&amp;author=GL%20Ryland&amp;author=PA%20Cowin&amp;volume=15&amp;publication_year=2014&amp;pages=732&amp;pmid=25167919&amp;doi=10.1186/1471-2164-15-732&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/5356755/bin/oncotarget-07-85529-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">oncotarget-07-85529-s001.pdf</a><sup> (2MB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Oncotarget are provided here courtesy of <strong>Impact Journals, LLC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.18632/oncotarget.13456"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/oncotarget-07-85529.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/5356755/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/5356755/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC5356755%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC5356755/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC5356755/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC5356755/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/27907908/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC5356755/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/27907908/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC5356755/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/5356755/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="21vLyu0xOFW3XpCa5Fs8PnJqb5MU5ROTEbVYkmt55nqn8v7blEQImvC6iXb78Cjo">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
